Search Results - "Andrae, D. A."
-
1
Early response predicts a sustained response to eluxadoline in patients with irritable bowel syndrome with diarrhoea in two Phase 3 studies
Published in Alimentary pharmacology & therapeutics (01-05-2017)“…Summary Background The mixed μ‐ and κ‐opioid receptor agonist and δ‐opioid receptor antagonist, eluxadoline, is licensed in the USA for the treatment of…”
Get full text
Journal Article -
2
Radar plots: A novel modality for displaying disparate data on the efficacy of eluxadoline for the treatment of irritable bowel syndrome with diarrhea
Published in Neurogastroenterology and motility (01-08-2018)“…Background Patients with irritable bowel syndrome with diarrhea (IBS‐D) experience a range of abdominal and bowel symptoms; successful management requires…”
Get full text
Journal Article -
3
A Phase 2 study of the novel fluoroquinolone JNJ-Q2 in community-acquired bacterial pneumonia
Published in Journal of antimicrobial chemotherapy (01-11-2013)Get full text
Journal Article -
4
PATIENT-RATED IMPACT ASSESSMENT FOR ROSACEA FACIAL REDNESS (IA-RFR): RESULTS OF TWO PHASE 3 PIVOTAL TRIALS OF OXYMETAZOLINE CREAM 1% VS VEHICLE
Published in Value in health (01-05-2017)“…OBJECTIVES: Persistent erythema associated with rosacea has considerable psychological and social impacts that are important to assess when evaluating…”
Get full text
Journal Article -
5
DEVELOPMENT AND VALIDATION OF THE IMPACT ASSESSMENT FOR ROSACEA FACIAL REDNESS (IA-RFR)
Published in Value in health (01-05-2017)“…OBJECTIVES: Persistent facial erythema (redness) associated with rosacea has considerable psychosocial impacts that are important components of treatment…”
Get full text
Journal Article -
6
The impact of treatment with eluxadoline on health-related quality of life among adult patients with irritable bowel syndrome with diarrhea
Published in Quality of life research (01-02-2019)“…Purpose Irritable bowel syndrome with diarrhea (IBS-D) significantly impacts health-related quality of life (HRQOL). This post hoc analysis of two phase III…”
Get full text
Journal Article -
7
Mapping the Irritable Bowel Syndrome Quality of Life Measure (IBS-QOL) to EQ-5D in Patients with Irritable Bowel Syndrome with Diarrhoea (IBS-D)
Published in Value in health (01-11-2016)Get full text
Journal Article -
8